Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by H. Lee Moffitt Cancer Center and Research Institute
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT01286038
First received: January 27, 2011
Last updated: June 19, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)